Delivery Order SPE2DB22D1106-SPE2DB25FFED1
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes with a ceiling value of $3,670.26. EUFLEXXA is a hyaluronic acid-based injectable treatment used for knee osteoarthritis pain management. This competitive delivery order, executed under firm fixed pricing, represents a continuation of the federal medical procurement relationship between the prime contractor and the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes in 2 ml quantities. This is a firm fixed price delivery order with a ceiling value of $2,575.50 and an ultimate completion date of July 30, 2025. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. EUFLEXXA is a viscosupplementation...
- The Defense Logistics Agency awarded a $36,127.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 20, 2025, with completion targeted for August 21, 2025. Euflexxa is a hyaluronic acid-based injectable used for knee osteoarthritis pain management. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes with a ceiling value of $6,754.59 on August 14, 2025. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and no set-aside designation was used. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,690.32 to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $11,067 delivery order to Amerisourcebergen Drug Corporation for 4561996235 EUFLEXXA 20 MG/2 ML SYRINGE. The firm fixed price order is for the delivery of 2ML syringes of EUFLEXXA, a medical device used to treat pain in osteoarthritis patients, to a location in Conshohocken, Pennsylvania. As the DLA supports procurement for the Department of Defense, this order was likely placed to supply military treatment facilities with this product. Amerisourcebergen...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, with a potential value of $2,987.28 and a completion date of February 26, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,618.45, is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract, valued at $3,003.66, has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization located in Conshohocken, Pennsylvania, serves as the prime contractor and is responsible for delivering the pharmaceutical product to...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The contract has a ceiling value of $2,869.16 and is a firm fixed-price delivery order. The period of performance extends to October 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...